World No Tobacco Day: smoking, nicotine and children Jørgen Vestbo, Jonathan Grigg, Charlotta Pisinger, Andy Bush Eur Respir J, 55 (5) 2001633; 10.1183/13993003.01633-2020 |    |
Severe Pulmonary Hypertension Management Across Europe (PHAROS): an ERS Clinical Research Collaboration Olivier Sitbon, Abílio Reis, Marc Humbert, Anton Vonk Noordegraaf, Marion Delcroix Eur Respir J, 55 (5) 2001047; 10.1183/13993003.01047-2020 |    |
Early consensus management for non-ICU acute respiratory failure SARS-CoV-2 emergency in Italy: from ward to trenches Michele Vitacca, Stefano Nava, Pierachille Santus, Sergio Harari Eur Respir J, 55 (5) 2000632; 10.1183/13993003.00632-2020 |    |
Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective David M.G. Halpin, Dave Singh, Ruth M. Hadfield Eur Respir J, 55 (5) 2001009; 10.1183/13993003.01009-2020 |    |
Which patients are SaPHe in sarcoidosis-associated pulmonary hypertension? Daniel Vis, Athénaïs Boucly, Marc Humbert, Jason Weatherald Eur Respir J, 55 (5) 2000700; 10.1183/13993003.00700-2020 |    |
TBX4 syndrome: a systemic disease highlighted by pulmonary arterial hypertension in its most severe form Eric D. Austin, C. Gregory Elliott Eur Respir J, 55 (5) 2000585; 10.1183/13993003.00585-2020 |    |
PLEASE, take a deep breath José M. Porcel Eur Respir J, 55 (5) 2000501; 10.1183/13993003.00501-2020 |    |
FENO as a biomarker guide for inhaled corticosteroid step down in patients with mild-to-moderate well-controlled asthma Anh Tuan Dinh-Xuan, Guy Brusselle Eur Respir J, 55 (5) 2001319; 10.1183/13993003.01319-2020 |    |
Looking back to go forward: adherence to inhaled therapy before biologic therapy in severe asthma Richard W. Costello, Breda Cushen Eur Respir J, 55 (5) 2000954; 10.1183/13993003.00954-2020 |    |
Bronchopulmonary dysplasia: a crime of opportunity? Aaron C. Ericsson Eur Respir J, 55 (5) 2000551; 10.1183/13993003.00551-2020 |    |
The right treatment for the right patient with COPD: lessons from the IMPACT trial Daiana Stolz, Marc Miravitlles Eur Respir J, 55 (5) 2000881; 10.1183/13993003.00881-2020 |    |
The search for the “healthy” blood eosinophil count Signe Vedel-Krogh Eur Respir J, 55 (5) 2000473; 10.1183/13993003.00473-2020 |    |
Effects of adopting the Global Lung Function Initiative 2017 reference equations on the interpretation of carbon monoxide transfer factor Danny J. Brazzale, Leigh M. Seccombe, Liam Welsh, Celia J. Lanteri, Claude S. Farah, Warren R. Ruehland Eur Respir J, 55 (5) 1901905; 10.1183/13993003.01905-2019 |    |
Structural determinants of long-term functional outcomes in young children with cystic fibrosis Lidija Turkovic, Daan Caudri, Tim Rosenow, Oded Breuer, Conor Murray, Harm A.W.M. Tiddens, Fiona Ramanauskas, Sarath C. Ranganathan, Graham L. Hall, Stephen M. Stick Eur Respir J, 55 (5) 1900748; 10.1183/13993003.00748-2019 |    |
Physiological predictors of survival in patients with sarcoidosis-associated pulmonary hypertension: results from an international registry Oksana A. Shlobin, Vasilis Kouranos, Scott D. Barnett, Esam H. Alhamad, Daniel A. Culver, Joseph Barney, Francis C. Cordova, Eva M. Carmona, Mary Beth Scholand, Marlies Wijsenbeek, Sivagini Ganesh, Elyse E. Lower, Peter J. Engel, John Wort, Laura Price, Athol U. Wells, Steven D. Nathan, Robert P. Baughman Eur Respir J, 55 (5) 1901747; 10.1183/13993003.01747-2019 |    |
Phenotype and outcome of pulmonary arterial hypertension patients carrying a TBX4 mutation Pierre Thoré, Barbara Girerd, Xavier Jaïs, Laurent Savale, Maria-Rosa Ghigna, Mélanie Eyries, Marilyne Levy, Caroline Ovaert, Amélie Servettaz, Anne Guillaumot, Claire Dauphin, Céline Chabanne, Emmanuel Boiffard, Vincent Cottin, Frédéric Perros, Gérald Simonneau, Olivier Sitbon, Florent Soubrier, Damien Bonnet, Martine Remy-Jardin, Ari Chaouat, Marc Humbert, David Montani Eur Respir J, 55 (5) 1902340; 10.1183/13993003.02340-2019 |    |
The Pleural Effusion And Symptom Evaluation (PLEASE) study of breathlessness in patients with a symptomatic pleural effusion Sanjeevan Muruganandan, Maree Azzopardi, Rajesh Thomas, Deirdre B. Fitzgerald, Yi Jin Kuok, Hui Min Cheah, Catherine A. Read, Charley A. Budgeon, Peter R. Eastwood, Susan Jenkins, Bhajan Singh, Kevin Murray, Y.C. Gary Lee Eur Respir J, 55 (5) 1900980; 10.1183/13993003.00980-2019 |    |
Using fractional exhaled nitric oxide to guide step-down treatment decisions in patients with asthma: a systematic review and individual patient data meta-analysis Kay Wang, Jan Y. Verbakel, Jason Oke, Alexander Fleming-Nouri, Josh Brewin, Nia Roberts, Norihiro Harada, Ryo Atsuta, Kazuhisa Takahashi, Kazutaka Mori, Tomoyuki Fujisawa, Toshihiro Shirai, Tomotaka Kawayama, Hiromasa Inoue, Stephen Lazarus, Stanley Szefler, Fernando Martinez, Dominick Shaw, Ian D. Pavord, Mike Thomas Eur Respir J, 55 (5) 1902150; 10.1183/13993003.02150-2019 |    |
Mepolizumab effectiveness and identification of super-responders in severe asthma Erin S. Harvey, David Langton, Constance Katelaris, Sean Stevens, Claude S. Farah, Andrew Gillman, John Harrington, Mark Hew, Vicky Kritikos, Naghmeh Radhakrishna, Philip Bardin, Matthew Peters, Paul N. Reynolds, John W. Upham, Melissa Baraket, Simon Bowler, Jeffrey Bowden, Jimmy Chien, Li Ping Chung, Christopher Grainge, Christine Jenkins, Gregory P. Katsoulotos, Joy Lee, Vanessa M. McDonald, Helen K. Reddel, Janet Rimmer, Peter A.B. Wark, Peter G. Gibson Eur Respir J, 55 (5) 1902420; 10.1183/13993003.02420-2019 |    |
Aberrant anti-viral response of natural killer cells in severe asthma Justine Devulder, Cécile Chenivesse, Valérie Ledroit, Stéphanie Fry, Pierre-Emmanuel Lobert, Didier Hober, Anne Tsicopoulos, Catherine Duez Eur Respir J, 55 (5) 1802422; 10.1183/13993003.02422-2018 |    |
Adherence to corticosteroids and clinical outcomes in mepolizumab therapy for severe asthma Gráinne d'Ancona, Joanne Kavanagh, Cris Roxas, Linda Green, Mariana Fernandes, Louise Thomson, Jaideep Dhariwal, Alexandra M. Nanzer, David J. Jackson, Brian D. Kent Eur Respir J, 55 (5) 1902259; 10.1183/13993003.02259-2019 |    |
Does treatment guided by exhaled nitric oxide fraction improve outcomes in subgroups of children with asthma? Shona S. Fielding, Marielle Pijnenburg, Johan de Jongste, Katherine Pike, Graham Roberts, Helen Petsky, Anne B. Chang, Maria Fritsch, Thomas Frischer, Stanley J. Szefler, Peter Gergen, Francoise Vermeulen, Robin Vael, Steve S. Turner Eur Respir J, 55 (5) 1901879; 10.1183/13993003.01879-2019 |    |
Dissimilarity of the gut–lung axis and dysbiosis of the lower airways in ventilated preterm infants David Gallacher, Emma Mitchell, Dagmar Alber, Richard Wach, Nigel Klein, Julian R. Marchesi, Sailesh Kotecha Eur Respir J, 55 (5) 1901909; 10.1183/13993003.01909-2019 |    |
Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis Wei-jie Guan, Wen-hua Liang, Yi Zhao, Heng-rui Liang, Zi-sheng Chen, Yi-min Li, Xiao-qing Liu, Ru-chong Chen, Chun-li Tang, Tao Wang, Chun-quan Ou, Li Li, Ping-yan Chen, Ling Sang, Wei Wang, Jian-fu Li, Cai-chen Li, Li-min Ou, Bo Cheng, Shan Xiong, Zheng-yi Ni, Jie Xiang, Yu Hu, Lei Liu, Hong Shan, Chun-liang Lei, Yi-xiang Peng, Li Wei, Yong Liu, Ya-hua Hu, Peng Peng, Jian-ming Wang, Ji-yang Liu, Zhong Chen, Gang Li, Zhi-jian Zheng, Shao-qin Qiu, Jie Luo, Chang-jiang Ye, Shao-yong Zhu, Lin-ling Cheng, Feng Ye, Shi-yue Li, Jin-ping Zheng, Nuo-fu Zhang, Nan-shan Zhong, Jian-xing He Eur Respir J, 55 (5) 2000547; 10.1183/13993003.00547-2020 |    |
Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study Rong-Hui Du, Li-Rong Liang, Cheng-Qing Yang, Wen Wang, Tan-Ze Cao, Ming Li, Guang-Yun Guo, Juan Du, Chun-Lan Zheng, Qi Zhu, Ming Hu, Xu-Yan Li, Peng Peng, Huan-Zhong Shi Eur Respir J, 55 (5) 2000524; 10.1183/13993003.00524-2020 |    |
Change in blood eosinophils following treatment with inhaled corticosteroids may predict long-term clinical response in COPD Alexander G. Mathioudakis, Andras Bikov, Philip Foden, Lies Lahousse, Guy Brusselle, Dave Singh, Jørgen Vestbo Eur Respir J, 55 (5) 1902119; 10.1183/13993003.02119-2019 |    |
The effect of exacerbation history on outcomes in the IMPACT trial David M.G. Halpin, Mark T. Dransfield, MeiLan K. Han, C. Elaine Jones, Sally Kilbride, Peter Lange, David A. Lipson, David A. Lomas, Fernando J. Martinez, Steve Pascoe, Dave Singh, Robert Wise, Gerard J. Criner Eur Respir J, 55 (5) 1901921; 10.1183/13993003.01921-2019 |    |
Earlier palliative home care is associated with patient-centred medical resource utilisation and lower costs in the last 30 days before death in COPD: a population-level decedent cohort study Charlotte Scheerens, Kristof Faes, Peter Pype, Kim Beernaert, Guy Joos, Eric Derom, Joachim Cohen, Luc Deliens, Kenneth Chambaere Eur Respir J, 55 (5) 1901139; 10.1183/13993003.01139-2019 |    |
Blood eosinophil count in the general population: typical values and potential confounders Sylvia Hartl, Marie-Kathrin Breyer, Otto C. Burghuber, Alina Ofenheimer, Andrea Schrott, Matthias H. Urban, Alvar Agusti, Michael Studnicka, Emiel F.M. Wouters, Robab Breyer-Kohansal Eur Respir J, 55 (5) 1901874; 10.1183/13993003.01874-2019 |    |
Eosinophils, basophils and type 2 immune microenvironments in COPD-affected lung tissue Prajakta Jogdand, Premkumar Siddhuraj, Michiko Mori, Caroline Sanden, Jimmie Jönsson, Andrew F. Walls, Jennifer Kearley, Alison A. Humbles, Roland Kolbeck, Leif Bjermer, Paul Newbold, Jonas S. Erjefält Eur Respir J, 55 (5) 1900110; 10.1183/13993003.00110-2019 |    |
Predictors of progression in systemic sclerosis patients with interstitial lung disease Oliver Distler, Shervin Assassi, Vincent Cottin, Maurizio Cutolo, Sonye K. Danoff, Christopher P. Denton, Jörg H.W. Distler, Anna-Maria Hoffmann-Vold, Sindhu R. Johnson, Ulf Müller Ladner, Vanessa Smith, Elizabeth R. Volkmann, Toby M. Maher Eur Respir J, 55 (5) 1902026; 10.1183/13993003.02026-2019 |    |
Obstructive sleep apnoea treatment and blood pressure: which phenotypes predict a response? A systematic review and meta-analysis Martino F. Pengo, Davide Soranna, Alice Giontella, Elisa Perger, Paola Mattaliano, Esther Irene Schwarz, Carolina Lombardi, Grzegorz Bilo, Antonella Zambon, Joerg Steier, Gianfranco Parati, Pietro Minuz, Cristiano Fava Eur Respir J, 55 (5) 1901945; 10.1183/13993003.01945-2019 |    |
Re-imagining cystic fibrosis care: next generation thinking Catherine Rang, Dominic Keating, John Wilson, Tom Kotsimbos Eur Respir J, 55 (5) 1902443; 10.1183/13993003.02443-2019 |    |
Clinical phenotypes of SARS-CoV-2: implications for clinicians and researchers Jordi Rello, Enrico Storti, Mirko Belliato, Ricardo Serrano Eur Respir J, 55 (5) 2001028; 10.1183/13993003.01028-2020 |    |
Evaluating the sensitivity and specificity of NEATstik technology compared to an activity-based immunoassay in sputum samples from participants with COPD Samantha J. Thulborn, Jennifer L. Cane, Clare Connolly, Catherine Borg, Kelly L. Moffitt, David Ribeiro, Charlene Robb, Richard E.K. Russell, Mona Bafadhel Eur Respir J, 55 (5) 1902412; 10.1183/13993003.02412-2019 |    |
Association between age and clinical characteristics and outcomes of COVID-19 Yang Liu, Bei Mao, Shuo Liang, Jia-Wei Yang, Hai-Wen Lu, Yan-Hua Chai, Lan Wang, Li Zhang, Qiu-Hong Li, Lan Zhao, Yan He, Xiao-Long Gu, Xiao-Bin Ji, Li Li, Zhi-Jun Jie, Qiang Li, Xiang-Yang Li, Hong-Zhou Lu, Wen-Hong Zhang, Yuan-Lin Song, Jie-Ming Qu, Jin-Fu Xu Eur Respir J, 55 (5) 2001112; 10.1183/13993003.01112-2020 |    |
Short-term outcomes of COVID-19 and risk factors for progression Li Long, Xiansheng Zeng, Xu Zhang, Wei Xiao, E Guo, Wenzhi Zhan, Xuejiao Yang, Chunyan Li, Caiyun Wu, Tingting Xu, Chen Zhan, Yuehan Chen, Mei Jiang, Nanshan Zhong, Kefang Lai Eur Respir J, 55 (5) 2000990; 10.1183/13993003.00990-2020 |    |
Celecoxib in lymphangioleiomyomatosis: results of a phase I clinical trial Souheil El-Chemaly, Angelo Taveira-DaSilva, Shefali Bagwe, Katarzyna Klonowska, Tania Machado, Anthony M. Lamattina, Hilary J. Goldberg, Amanda M. Jones, Patricia Julien-Williams, Rie Maurer, Ivan O. Rosas, Elizabeth P. Henske, Joel Moss, David J. Kwiatkowski Eur Respir J, 55 (5) 1902370; 10.1183/13993003.02370-2019 |    |
External heated humidification during non-invasive ventilation set up: results from a pilot cross-over clinical trial Swapna Mandal, Michelle Ramsay, Eui-Sik Suh, Rachel Harding, April Thompson, Abdel Douiri, John Moxham, Patrick Brian Murphy, Nicholas Hart Eur Respir J, 55 (5) 1901126; 10.1183/13993003.01126-2019 |    |
Highly efficient genome editing in primary human bronchial epithelial cells differentiated at air–liquid interface Radu Rapiteanu, Tina Karagyozova, Natalie Zimmermann, Kuljit Singh, Gareth Wayne, Matteo Martufi, Nikolai N. Belyaev, Edith M. Hessel, David Michalovich, Ricardo Macarron, Wendy C. Rowan, William J. Cairns, Jan Roger, Joanna Betts, Soren Beinke, Klio Maratou Eur Respir J, 55 (5) 1900950; 10.1183/13993003.00950-2019 |    |
COVID-19: minimising risk to healthcare workers during aerosol-producing respiratory therapy using an innovative constant flow canopy Yochai Adir, Ori Segol, Dmitry Kompaniets, Hadas Ziso, Yechiam Yaffe, Irina Bergman, Erez Hassidov, Arieh Eden Eur Respir J, 55 (5) 2001017; 10.1183/13993003.01017-2020 |    |
The influence of preventive strategies on the COVID-2019 epidemic in Shenzhen, China Kai Yang, Lingwei Wang, Furong Li, Dandan Chen, Xi Li, Chen Qiu, Rongchang Chen Eur Respir J, 55 (5) 2000599; 10.1183/13993003.00599-2020 |    |
ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19 Janice M. Leung, Chen X. Yang, Anthony Tam, Tawimas Shaipanich, Tillie-Louise Hackett, Gurpreet K. Singhera, Delbert R. Dorscheid, Don D. Sin Eur Respir J, 55 (5) 2000688; 10.1183/13993003.00688-2020 |    |
FVC variability in patients with idiopathic pulmonary fibrosis and role of 6-min walk test to predict further change Steven D. Nathan, Ming Yang, Elizabeth A. Morgenthien, John L. Stauffer Eur Respir J, 55 (5) 1902151; 10.1183/13993003.02151-2019 |    |
Inspiratory vocal cord closure in COPD Paul Leong, Laurence E. Ruane, Debra Phyland, Joo Koh, Martin I. MacDonald, Malcom Baxter, Kenneth K. Lau, Kais Hamza, Philip G. Bardin Eur Respir J, 55 (5) 1901466; 10.1183/13993003.01466-2019 |    |
Therapeutic drug monitoring using saliva as matrix: an opportunity for linezolid, but challenge for moxifloxacin Simone H.J. van den Elsen, Onno W. Akkerman, Erwin M. Jongedijk, Mireille Wessels, Samiksha Ghimire, Tjip S. van der Werf, Daan J. Touw, Mathieu S. Bolhuis, Jan-Willem C. Alffenaar Eur Respir J, 55 (5) 1901903; 10.1183/13993003.01903-2019 |    |
Forced oscillation technique for optimising PEEP in ventilated extremely preterm infants Linda Wallström, Chiara Veneroni, Emanuela Zannin, Raffaele L. Dellacà, Richard Sindelar Eur Respir J, 55 (5) 1901650; 10.1183/13993003.01650-2019 |    |
Magnetic resonance imaging of pulmonary arterial compliance after pulmonary endarterectomy Stefano Ghio, Gabriele Crimi, Stefania Guida, Adele Valentini, Anna Celentano, Maurizio Pin, Claudia Raineri, Annalisa Turco, Laura Scelsi, Luigi Oltrona Visconti, Robert Naeije, Andrea Maria D'Armini Eur Respir J, 55 (5) 1902171; 10.1183/13993003.02171-2019 |    |
No association of COVID-19 transmission with temperature or UV radiation in Chinese cities Ye Yao, Jinhua Pan, Zhixi Liu, Xia Meng, Weidong Wang, Haidong Kan, Weibing Wang Eur Respir J, 55 (5) 2000517; 10.1183/13993003.00517-2020 |    |
Minimising the environmental impact of inhaled therapies Lauri Lehtimäki, Unnur Björnsdóttir, Christer Janson, Tari Haahtela Eur Respir J, 55 (5) 2000721; 10.1183/13993003.00721-2020 |    |
Minimising the environmental impact of inhaled therapies: problems with policy on low carbon inhalers Duncan Keeley, Jane E. Scullion, Omar S. Usmani Eur Respir J, 55 (5) 2001122; 10.1183/13993003.01122-2020 |    |
We must screen refugees to ensure no one is left behind: a case study of Malaysia Yen Jun Wong, Shaun Wen Huey Lee Eur Respir J, 55 (5) 2000395; 10.1183/13993003.00395-2020 |    |
Careful consideration of the bleeding caused by transbronchial lung cryobiopsies Arnaud Bourdin, Micaela Romagnoli, Anne Sophie Gamez, Kheira Hireche, Jean Philippe Berthet, Jean Pierre Mallet, Isabelle Vachier, Stefano Nava, Paul Reynaud, Nicolas Molinari, Carey Suehs Eur Respir J, 55 (5) 1902415; 10.1183/13993003.02415-2019 |    |
Correspondence regarding “T-box protein 4 mutation causing pulmonary arterial hypertension and lung disease”: a single-centre case series Samara M.A. Jansen, Lieke van den Heuvel, Lilian J. Meijboom, Suzanne I.M. Alsters, Anton Vonk Noordegraaf, Arjan Houweling, Harm Jan Bogaard Eur Respir J, 55 (5) 1902272; 10.1183/13993003.02272-2019 |    |
High-flow nasal cannula for COVID-19 patients: low risk of bio-aerosol dispersion Jie Li, James B. Fink, Stephan Ehrmann Eur Respir J, 55 (5) 2000892; 10.1183/13993003.00892-2020 |    |
Cancer in the time of COVID-19: expert opinion on how to adapt current practice Jo Raskin, Marnix Lebeer, Charlotte De Bondt, Reinier Wener, Annelies Janssens, Jan P. van Meerbeeck Eur Respir J, 55 (5) 2000959; 10.1183/13993003.00959-2020 |    |
What constitutes a “clinically significant” bronchodilator response in children? Fatma Guezguez, Helmi Ben Saad Eur Respir J, 55 (5) 2000207; 10.1183/13993003.00207-2020 |    |
A clinically significant bronchodilator response in children: how should it be measured? Carmen C.M. de Jong, Eva S.L. Pedersen, R. Mozun, Myrofora Goutaki, Daniel Trachsel, Juerg Barben, Claudia E. Kuehni Eur Respir J, 55 (5) 2000636; 10.1183/13993003.00636-2020 |    |
A rational approach to e-cigarettes: challenging ERS policy on tobacco harm reduction John Britton, Jacob George, Linda Bauld, Sanjay Agrawal, John Moxham, Deborah Arnott, Ann McNeill, Nicholas S. Hopkinson Eur Respir J, 55 (5) 2000166; 10.1183/13993003.00166-2020 |    |
A rational approach to e-cigarettes: challenging ERS policy on tobacco harm reduction Charlotta Pisinger, Jørgen Vestbo Eur Respir J, 55 (5) 2000355; 10.1183/13993003.00355-2020 |    |
The ERS approach to e-cigarettes is entirely rational Andrew Bush, Jayesh Mahendra Bhatt, Will Carroll, Frances Child, Gary Connett, Iolo Doull, Francis Gilchrist, Jonathan Grigg, Simon Langton-Hewer, Julian Legg, Warren Lenney, James Paton, Michael Shields, Ian Sinha Eur Respir J, 55 (5) 2000413; 10.1183/13993003.00413-2020 |    |
“Detection of SV40 like viral DNA and viral antigens in malignant pleural mesothelioma.” M. Ramael, J. Nagels, H. Heylen, S. De Schepper, J. Paulussen, M. De Maeyer and C. Van Haesendonck. Eur Respir J 1999; 14: 1381–1386.
Eur Respir J, 55 (5) 9951381; 10.1183/13993003.51381-1999 |   |